Ginkgo Bioworks Holdings, Inc. (DNA) reached $15.24 at the closing of the latest trading day, reflecting a -5.28% change compared to its last close.

Ginkgo Bioworks Holdings, Inc. (DNA) concluded the recent trading session at $16.14, signifying a +1.06% move from its prior day's close.

Researchers from the Carl R. Woese Institute for Genomic Biology at the University of Illinois Urbana-Champaign will partner ...

At its 15th anniversary event in Ede on October 15, Wageningen-based agrifood accelerator StartLife made two major ...

The U.S. government has agreed to loan privately-held biotechnology firm Ginkgo Bioworks $1.1 billion for COVID-19 testing and the production of raw materials for therapies that may help address ...

Recursion Pharmaceuticals' stock rises on heavy trading volume, with investors eyeing its AI-designed cancer drug REC-3565 ...

E. coli is the field's main "workhorse" says Prof Wallace, who has also genetically engineered it in the lab to turn plastic ...

The work, described in a preprint paper, has the potential to create new treatments and accelerate research into artificially ...

Dublin, Sept. 29, 2025 (GLOBE NEWSWIRE) -- The "Global Biochemicals Market 2026-2036" report has been added to ResearchAndMarkets.com's offering. The global biochemicals market represents one of the ...

A Multi-Party Team represented by Carnegie Mellon University researchers and private industry partners has secured an award of up to $26.7 million from the Advanced Research Projects Agency for Health ...

Stanford and Arc Institute used AI to design viruses that kill bacteria, sparking hope for new therapies and warnings over biosecurity risks.